Latest News

Regeneron is investing USD 150 million in equity and upfront payments to acquire half of the global development and commercialization rights for TSRA-196.

The closure announcement follows Valneva’s financial results for the first nine months of 2025, which revealed mixed performance.

The study found that over half of heart attacks in women under 65 were linked to nontraditional causes such as spontaneous coronary artery dissection (SCAD), embolism, and other conditions unrelated to artery plaque.

The guidance comes as more than one billion people worldwide currently live with obesity, a number projected to double by 2030 without decisive intervention.

This oral formulation offers a more convenient delivery method compared to intravenous treatments.

Recon DL is the first mammography technology to combine deep learning with iterative reconstruction methods to enhance digital breast tomosynthesis (DBT) image quality.

Philips has pioneered this detector-based spectral CT approach that produces multiple spectral outputs from a single scan without sacrificing performance or increasing scan time.

AdipoLABs operates as a Ministry of Health (MOH)-registered medical device establishment under the Medical Device Authority (MDA), providing regulatory credibility and demonstrating commitment to quality and innovation.

The total USD20.9 million funding will be divided into two tranches, with the release of the second contingent on outcomes from the ongoing ‘SEALS’ phase 2 clinical trial.

The facility will serve as a central hub for driving innovation, fostering partnerships, and delivering enhanced customer support throughout the region.